Clinical Trial Update: Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD) [Phase 2, Phase 3]

View source ↗

Summary

A completed mid-to-late-stage trial investigating ketamine for PTSD (Phase 2/Phase 3) with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Posttraumatic Stress Disorder (PTSD) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-02-11